Key facts
- This page summarizes Amit Sachdev's Form 4 filing for VERTEX PHARMACEUTICALS INC / MA (VRTX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 19 Feb 2026, 16:24.
Amit Sachdev - 17 Feb 2026 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)
- Reporting relationship
- EVP Chief Patient & Ext Af Off
- Issuer ticker
- VRTX
- Reported as of
- 17 Feb 2026
- Net transaction value
- -$1,035,225
- SEC form
- 4
- Accepted by SEC
- 19 Feb 2026, 16:24:59 UTC
- Prior SEC filing
- 18 Feb 2026
- Next SEC filing
- 23 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christiana Stevenson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Amit Sachdev filed Form 4 for VERTEX PHARMACEUTICALS INC / MA (VRTX) on 19 Feb 2026.
Change
- Previous filing in this sequence was filed on 18 Feb 2026.
- Current net transaction value: -$1,035,225.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001406338
Primary reporting owner
Sachdev Amit
- Relationship
- EVP Chief Patient & Ext Af Off
- Address
- C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON
- Signature
- /s/ Christiana Stevenson, Attorney-in-Fact
- Signature date
- 19 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VRTX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,789
- Change %
- +8.9%
- Price
- $0.000000
- Shares after
- 71,182
- Date
- 17 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
VRTX
transaction
Common Stock
Tax liability
- Transaction value
- $1,035,225
- Shares
- -2,140
- Change %
- -3%
- Price
- $483.75
- Shares after
- 69,042
- Date
- 17 Feb 2026
- Ownership
- Direct
VRTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 882
- Date
- 17 Feb 2026
- Ownership
- 401(k)
VRTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 9,301
- Date
- 17 Feb 2026
- Ownership
- Held in Trust
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Restricted stock unit award that vests in installments beginning on February 20, 2027.